Use of an anti-vascular endothelial growth factor antibody in a pharmacokinetic strategy to increase the efficacy of intraperitoneal chemotherapy.

Use of an anti-vascular endothelial growth factor antibody in a pharmacokinetic strategy to increase the efficacy of intraperitoneal chemotherapy.

Item
http://www.wikidata.org/entity/Q37168526
Phase 1/pharmacology study of intraperitoneal topotecan alone and with cisplatin: potential for consolidation in ovarian cancer.Multiscale tumor spatiokinetic model for intraperitoneal therapyPK/TD modeling for prediction of the effects of 8C2, an anti-topotecan mAb, on topotecan-induced toxicity in mice.Systemic administration of bevacizumab prolongs survival in an in vivo model of platinum pre-treated ovarian cancerAngiogenesis-Related Markers and Prognosis After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Metastatic Colorectal CancerApplication of PBPK modeling to predict monoclonal antibody disposition in plasma and tissues in mouse models of human colorectal cancerThe pharmacokinetic/pharmacodynamic pipeline: translating anticancer drug pharmacology to the clinic.Interactions Between Therapeutic Proteins and Small Molecules: The Shared Role of Perpetrators and Victims.Enhanced antitumor activity of low-dose continuous administration schedules of topotecan in prostate cancer.Pharmacokinetic mAb-mAb interaction: anti-VEGF mAb decreases the distribution of anti-CEA mAb into colorectal tumor xenografts.Effects of intraperitoneal bevacizumab administration on colonic anastomosis and early postoperative adhesion formation.Mathematical modeling of intraperitoneal drug delivery: simulation of drug distribution in a single tumor nodule.
P2860

Use of an anti-vascular endothelial growth factor antibody in a pharmacokinetic strategy to increase the efficacy of intraperitoneal chemotherapy.

Item
http://www.wikidata.org/entity/Q37168526
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 February 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Use of an anti-vascular endoth ...... intraperitoneal chemotherapy.
@en
Use of an anti-vascular endoth ...... intraperitoneal chemotherapy.
@nl
type
label
Use of an anti-vascular endoth ...... intraperitoneal chemotherapy.
@en
Use of an anti-vascular endoth ...... intraperitoneal chemotherapy.
@nl
prefLabel
Use of an anti-vascular endoth ...... intraperitoneal chemotherapy.
@en
Use of an anti-vascular endoth ...... intraperitoneal chemotherapy.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P921
P932
P356
P1433
P1476
Use of an anti-vascular endoth ...... intraperitoneal chemotherapy.
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P921
P932